Patients and Professionals for Customized Care

Recently the FDA announced that
it will “halt” the compounding of hormone treatments that contain estriol. Estriol is a
common and critical component of many bio-identical hormone therapies (including Bi-Est and Tri-Est) that meets
standards that were set by Congress.
If the FDA has their way, you will lose this access to vital treatment options.
We need your help. For more information & how you can make a difference, visit
www.savemymedicine.org today.